Abatitor 250 mg Tablet
  1. Home
  2. Pharma Products
  3. Torrent Pharmaceuticals Ltd
  4. Abatitor 250 mg Tablet

Abatitor 250 mg Tablet

Abatitor 250 mg Tablet contains abiraterone acetate 250 mg, an androgen biosynthesis inhibitor used as hormone therapy for prostate cancer. It is used for advanced prostate cancer in specific treatment settings, generally alongside a corticosteroid. The tablet should be taken on an empty stomach as prescribed by the treating physician.

BUY NOW

Category

Abiraterone acetate works by inhibiting CYP17, an enzyme involved in androgen production, thereby reducing hormones that can support prostate cancer growth. Abatitor 250 mg Tablet is marketed by Torrent Pharmaceuticals Ltd and is available in 30- and 120-tablet bottle presentations. It should be swallowed whole and taken at least one hour before or two hours after food because food can increase abiraterone exposure. Regular monitoring of liver function, blood pressure, potassium levels, and fluid retention may be required during treatment.

Technical Specification

Specification Details
Active Ingredient Abiraterone Acetate
Strength 250 mg
Dosage Form Tablet
Therapeutic Class Anti-neoplastic
Route of Administration Oral
Manufacturer/Marketer Torrent Pharmaceuticals Ltd

Product Also Known As

Abatitor 250 mg Tablet, Abatitor 250mg Tablet, Abiraterone Acetate 250 mg Tablet, Abiraterone 250 mg Tablet, Abiraterone Anticancer Tablet, Abiraterone Prostate Cancer Tablet, Androgen Biosynthesis Inhibitor Tablet

Related products